StockData
Ginkgo Bioworks Holdings, Inc. logo

Ginkgo Bioworks Holdings, Inc. (DNA) stock

DNANYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/3013% below fair value
$8.44+0.12 (+1.44%)

Close on Nov 18, 2026Market cap $568.35MP/E –Yield –

Ginkgo Bioworks market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Ginkgo Bioworks's market cap was $653.04M on Nov 11, 2026, against $527.44M a year earlier. Over the last 5 years it ranged from $309.88M to $12.35B, with a median of $1.07B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$653.04M+38.3%
2025Dec 31, 2025$472.31M-9.4%
2024Dec 31, 2024$521.27M-84.4%
2023Dec 29, 2023$3.33B+19.7%
2022Dec 30, 2022$2.79B-77.5%
2021Dec 31, 2021$12.35B–

More Ginkgo Bioworks figures

See a number that looks wrong?